Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
TipRanks Clinical-Trials-Auto-Generated Newsdesk
TipRanks Reporter
TipRanks’s Recent Articles
Crescent Biopharma Advances CR-001 Cancer Trial Into First-in-Human Stage
Crescent Biopharma, Inc. ($CBIO) announced an update on their ongoing clinical study. Study Overview Crescent Biopharma, Inc. has...
17h ago
CBIO
EssilorLuxottica Targets Childhood Myopia With New Eye-Imaging Study: What Investors Should Watch
Essilorluxottica (OTC) ($ESLOY) announced an update on their ongoing clinical study. Essilor International, part of EssilorLuxottica (OTC: ESLOY),...
17h ago
ESLOY
NeOnc’s Intranasal NEO100 Trial Marks a New Step in Pediatric Brain Tumor Investing
NeOnc Technologies Holdings, Inc. ($NTHI) announced an update on their ongoing clinical study. Study Overview NeOnc Technologies Holdings,...
17h ago
NTHI
Novo Nordisk’s AMAZE 1 Obesity Trial Signals Next Wave in Weight-Loss Pipeline
Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Study Overview: Novo Nordisk has launched AMAZE...
17h ago
NVO
TransMedics’ DENOVO Trial: New Lung Preservation Study Could Shape Future Growth for TMDX
Transmedics Group ($TMDX) announced an update on their ongoing clinical study. Study Overview: The “Decreasing Edema With a...
17h ago
TMDX
Natera Targets Endometrial Cancer With New Signatera Trial, Expanding Its MRD Opportunity
Natera Inc. ($NTRA) announced an update on their ongoing clinical study. Natera’s new trial, “Circulating Tumor DNA Assessment...
17h ago
NTRA
Denali Therapeutics Advances New Early-Stage Alzheimer’s Drug Into Phase 1b Testing
Denali Therapeutics ($DNLI) announced an update on their ongoing clinical study. Study Overview Denali Therapeutics is launching a...
17h ago
DNLI
Pfizer Advances CGRP Migraine Asset With New Bioequivalence Study
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Tests New Migraine Drug Formulation in...
17h ago
PFE
Pfizer Completes Key China Phase 3 Trial for Migraine Drug Rimegepant
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Advances Migraine Prevention Study in China...
17h ago
PFE
Novo Nordisk’s CagriSema Trial Completion: What Investors Should Watch in the Next Phase of the Diabetes and Obesity Race
Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Novo Nordisk’s CagriSema Trial Signals Next Wave...
17h ago
NVO
UroGen’s Phase 1 UGN-301 Bladder Cancer Trial Completion: What Investors Should Watch Next
Urogen Pharma ($URGN) announced an update on their ongoing clinical study. Study OverviewUroGen Pharma’s Phase 1 trial, officially...
17h ago
URGN
AstraZeneca’s Imfinzi Post‑Marketing Study in Japan: What the Completed Safety Tracking Means for Investors
AstraZeneca ($AZN) announced an update on their ongoing clinical study. AstraZeneca has completed a post‑marketing study in Japan...
17h ago
AZN
Sanofi Terminates Early-Stage SAR444200 Cancer Trial: What Investors Need to Know
Sanofi ($SNYNF) announced an update on their ongoing clinical study. Study Overview: Sanofi’s terminated Phase 1/2 study, officially...
17h ago
SNYNF
Sanofi’s Pediatric Eliglustat Trial Completion: What It Means for Gaucher Franchise Growth
Sanofi ($SNYNF) announced an update on their ongoing clinical study. Sanofi Advances Pediatric Gaucher Treatment With Eliglustat Study...
17h ago
SNYNF
Regeneron Ends Phase 2 Heart Failure Trial for REGN5381: What Investors Should Know
Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals has terminated a mid-stage heart...
17h ago
REGN
AstraZeneca’s Atuliflapon Asthma Trial Reaches Completion: What Investors Should Watch Next
AstraZeneca ($AZN) announced an update on their ongoing clinical study. Study Overview AstraZeneca is running a mid-stage trial...
17h ago
AZN
Eli Lilly Expands Bipolar Disorder Pipeline With New Phase 2 Brenipatide Trial
Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. Eli Lilly is advancing its...
2d ago
LLY
AstraZeneca Deepens Its Rare Disease Footprint With New Real‑World NMOSD Study in Russia
AstraZeneca ($AZN) announced an update on their ongoing clinical study. Study Overview — AstraZeneca is running a real‑world...
2d ago
AZN
AstraZeneca Advances Prostate Cancer Pipeline With New ANDROMEDA Trial on AZD9750
AstraZeneca ($AZN) announced an update on their ongoing clinical study. Study OverviewThe ANDROMEDA trial is a Phase I/II...
2d ago
AZN
AstraZeneca Builds Real-World Edge in Rare Neuromuscular Disease With New Russian gMG Study
AstraZeneca ($AZN) announced an update on their ongoing clinical study. Study OverviewAstraZeneca is running a large observational study...
2d ago
AZN
Natera’s SCORE Study Builds Real-World Evidence for Cancer MRD Testing
Natera Inc. ($NTRA) announced an update on their ongoing clinical study. The SCORE (Sample Collection for Ongoing Research...
2d ago
NTRA
Sanofi Advances Balinatunfib With New Cardiac Safety Study in Healthy Volunteers
Sanofi SA ($SNY) announced an update on their ongoing clinical study. Study Overview Sanofi is running a Phase...
2d ago
SNY
Sanofi Targets Senior Flu Market With New Efluelda Safety Study in Korea
Sanofi SA ($SNY) announced an update on their ongoing clinical study. Study Overview Sanofi has launched a post‑marketing...
2d ago
SNY
Mineralys Targets Sleep Apnea and Hypertension With Lorundrostat: What Investors Should Watch
Mineralys Therapeutics, Inc. ($MLYS) announced an update on their ongoing clinical study. Mineralys Therapeutics (MLYS) has completed a...
2d ago
MLYS
Pfizer Ends Mid-Stage Lupus Skin Trial, Trimming a Small but Promising Autoimmune Option
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Study Overview Pfizer is running a Phase...
2d ago
PFE
Rallybio Terminates Phase 2 FNAIT Pregnancy Study: What Investors Need to Know
Rallybio Corporation ($RLYB) announced an update on their ongoing clinical study. Rallybio’s latest update centers on a Phase...
2d ago
RLYB
AstraZeneca’s AZD5004 Diabetes Trial Reaches Key Phase IIb Milestone
AstraZeneca ($AZN) announced an update on their ongoing clinical study. Study OverviewAstraZeneca is running a Phase IIb trial...
2d ago
AZN
Argenx Advances Combo Strategy in Myasthenia Gravis With New ADAPT Forward Study
Argenx ($ARGX) announced an update on their ongoing clinical study. ADAPT Forward 1 (NCT07284420) is a Phase 2a...
3d ago
ARGX
Biogen Advances Presymptomatic SMA Strategy With New Salanersen Trial
Biogen Inc. ($BIIB) announced an update on their ongoing clinical study. Study OverviewThis Phase 3 Biogen study, officially...
3d ago
BIIB
C4 Therapeutics Sets Up New Combination Trial in Multiple Myeloma: What Investors Should Watch
C4 Therapeutics, Inc. ($CCCC) announced an update on their ongoing clinical study. C4 Therapeutics Advances Early Multiple Myeloma...
3d ago
CCCC
Pfizer’s New Colorectal Cancer Trial Puts PF-08634404 Head-to-Head With a Market Standard
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Study OverviewThis Phase 3 Pfizer study, officially...
3d ago
PFE
ADAPT Forward: How Argenx’s New Myasthenia Gravis Study Could Shape Its Growth Story
Argenx ($ARGX) announced an update on their ongoing clinical study. ADAPT Forward: Argenx Explores New Regimens in Myasthenia...
3d ago
ARGX
GSK Advances New First-in-Human Prostate Cancer Drug Into Early Clinical Testing
GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. Study Overview – GlaxoSmithKline (GSK) is launching a...
3d ago
GSK
Pfizer’s Phase 3 C. Difficile Vaccine Study Targets a New Niche in the Adult Vaccine Market
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Study Overview Pfizer is running a late-stage...
3d ago
PFE
AstraZeneca Deepens Respiratory Pipeline With New China-Focused Bronchiectasis Study
AstraZeneca ($AZN) announced an update on their ongoing clinical study. AstraZeneca (AZN) is sponsoring a new observational study...
3d ago
AZN
Pfizer Advances New Lung Cancer Combo in Global Phase 2/3 Trial: What Investors Should Watch
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Study Overview Pfizer is running a global...
3d ago
PFE
Pfizer’s Abrocitinib Atopic Dermatitis Study Nears Data Milestone: What Investors Should Watch
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Study Overview: Pfizer is running a large,...
3d ago
PFE
Bristol-Myers Squibb Advances Liver Cancer Combo as Key Trial Reaches Completion
Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Study Overview This Bristol-Myers Squibb (BMY)...
3d ago
BMY
United Therapeutics’ Phase 3 Ralinepag Trial Reaches Completion, Setting Up a Key Catalyst in Pulmonary Arterial Hypertension
United Therapeutics Corp. ($UTHR) announced an update on their ongoing clinical study. Study Overview: United Therapeutics is running...
3d ago
UTHR
AstraZeneca’s Real‑World Tezepelumab Study in Spain: What Investors Should Watch
AstraZeneca ($AZN) announced an update on their ongoing clinical study. Study Overview – The study, officially titled “Observational...
3d ago
AZN
AbbVie’s ABBV-932 Bipolar Depression Trial Reaches Completion: What Investors Should Watch Next
Abbvie ($ABBV) announced an update on their ongoing clinical study. Study Overview: AbbVie is running a Phase 2...
3d ago
ABBV
AbbVie’s ABBV-243 Phase 1 Trial: What Early Safety Work Means for Long-Term Investors
Abbvie ($ABBV) announced an update on their ongoing clinical study. Study Overview AbbVie is running a Phase 1...
6d ago
ABBV
BioNTech and Bristol-Myers Squibb Push Deeper Into Pancreatic Cancer With New Phase II Trial
Bristol-Myers Squibb Company ($BMY), Biontech Se Sponsored Adr ($BNTX) announced an update on their ongoing clinical study. Study...
6d ago
BMY
BNTX
Bayer’s New Phase 4 ATTR-CM Study Tests Switching From Tafamidis to Acoramidis
Bayer AG ($BAYRY) announced an update on their ongoing clinical study. Bayer Explores Switch to New ATTR-CM Therapy...
6d ago
BAYRY
Arrowhead’s ARO-DIMERPA Trial Advances in Mixed Hyperlipidemia: What Investors Should Watch
Arrowhead Pharmaceuticals, Inc. ($ARWR) announced an update on their ongoing clinical study. Study Overview This Phase 1/2a study,...
6d ago
ARWR
Molecular Partners Advances DLL3 Radioligand Program With New Phase 1/2a Cancer Trial
Molecular Partners ($MLLCF) announced an update on their ongoing clinical study. Molecular Partners’ new phase 1/2a trial targets...
6d ago
MLLCF
AstraZeneca’s DAHLIA Lupus Study: Real‑World Data Could Strengthen Anifrolumab’s Long‑Term Investment Case
AstraZeneca ($AZN) announced an update on their ongoing clinical study. Study Overview – AstraZeneca is sponsoring an Italian...
6d ago
AZN
Climb Bio’s CLYM116 Moves Into First-in-Human Testing: What Early Investors Should Watch
Climb Bio, Inc. ($CLYM) announced an update on their ongoing clinical study. Study Overview Climb Bio, Inc. (ticker:...
6d ago
CLYM
Bayer’s FINE-REAL Korea Study Tracks Real-World Use of Finerenone in Diabetic Kidney Disease
Bayer AG ($BAYRY) announced an update on their ongoing clinical study. FINE-REAL Korea: Bayer Tracks Real-World Use of...
6d ago
BAYRY
Bayer’s New Parkinson’s Study Builds a Long-Term Data Edge, Not Near-Term Profits
Bayer AG ($BAYRY) announced an update on their ongoing clinical study. Bayer Tracks Real-World Progression in Treated Parkinson’s...
6d ago
BAYRY
SHOW MORE
You need to enable JavaScript to run this app.
